Company
Headquarters: Beijing, China
Employees: 715
CN¥2.88 Billion
CNY as of July 1, 2024
US$396.9 Million
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $121.36 B |
| Regeneron Pharmaceuticals, Inc. | $115.11 B |
| CSL Limited | $95.75 B |
| Marinomed Biotech AG | $75.67 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Boji Medical Technology Co., Ltd. provides professional services in various medical study phases in China. It offers services on regulatory affairs, pre-clinical research, clinical trial phases, post marketing study, clinical trial for medical devices, data management and biostatistics, and linical trial site management organization. The company was formerly known as Guangzhou Boji Medical & Biotechnological Co., Ltd. and changed its name to Boji Medical Technology Co., Ltd. in September 2021. Boji Medical Technology Co., Ltd. was founded in 1998 is headquartered in Guangzhou, China.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Guangzhou Boji Medical & Biotechnological Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300404 wb_incandescent